Seoul, South Korea

Mi-Kyung Min

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mogam Biotechnology Institute. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi-Kyung Min. Retrieved from https://idiyas.com/inventor/mi-kyung-min

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi-Kyung Min: Innovator in Hepatitis C Virus Research

Introduction

Mi-Kyung Min is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of processes related to the hepatitis C virus (HCV). Her innovative work has the potential to impact diagnostic and preventive measures against this viral infection.

Latest Patents

Mi-Kyung Min holds a patent for a process for preparing hepatitis C virus envelope glycoproteins. This invention involves a novel method utilizing Chinese Hamster Ovary (CHO) cells transformed with recombinant expression vectors containing the hepatitis C virus genome. The process allows for the massive production of HCV E1 and E2/NS1 envelope glycoproteins, which can be applied in the development of diagnostic reagents and potential preventive vaccines for HCV.

Career Highlights

Mi-Kyung Min is associated with the Mogam Biotechnology Institute, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing challenges in hepatitis C virus research.

Collaborations

Mi-Kyung Min collaborates with notable colleagues, including Joon-Sang Park and Jung-Seob Kim. These partnerships enhance the research efforts at the Mogam Biotechnology Institute and contribute to advancements in biotechnology.

Conclusion

Mi-Kyung Min's contributions to hepatitis C virus research exemplify the impact of innovative processes in biotechnology. Her work not only advances scientific understanding but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…